(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NT5E mRNA] CTD PMID:31150632 (-)-demecolcine increases expression ISO RGD:734028 6480464 Demecolcine results in increased expression of NT5E mRNA CTD PMID:23649840 1,2-dichloroethane increases expression ISO RGD:62249 6480464 ethylene dichloride results in increased expression of NT5E mRNA CTD PMID:28189721 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of NT5E mRNA CTD PMID:27840820 1-nitropyrene increases expression ISO RGD:734028 6480464 1-nitropyrene results in increased expression of NT5E mRNA CTD PMID:19041380 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of NT5E mRNA CTD PMID:26865667 17beta-estradiol multiple interactions ISO RGD:734028 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of NT5E mRNA more ... CTD PMID:20823114 more ... 17beta-estradiol decreases expression ISO RGD:734028 6480464 Estradiol results in decreased expression of NT5E mRNA CTD PMID:24758408 , PMID:25321415 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:62249 6480464 Tetrachlorodibenzodioxin results in decreased expression of NT5E mRNA CTD PMID:21354282 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62249 6480464 Tetrachlorodibenzodioxin affects the expression of NT5E mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:734028 6480464 Tetrachlorodibenzodioxin affects the expression of NT5E mRNA CTD PMID:22298810 , PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:734028 6480464 Tetrachlorodibenzodioxin results in decreased expression of NT5E mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62249 6480464 Tetrachlorodibenzodioxin results in increased expression of NT5E mRNA CTD PMID:19933214 , PMID:21889950 2,4-dinitrobenzenesulfonic acid multiple interactions ISO RGD:62249 6480464 [2, 4-dinitrobenzenesulfonic acid co-treated with GR 159897] results in increased expression of NT5E mRNA CTD PMID:30116771 2,4-dinitrobenzenesulfonic acid decreases expression ISO RGD:62249 6480464 2, 4-dinitrobenzenesulfonic acid results in decreased expression of NT5E mRNA CTD PMID:30116771 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of NT5E mRNA CTD PMID:15543949 3,3',5-triiodo-L-thyronine increases activity EXP 6480464 Triiodothyronine results in increased activity of NT5E protein CTD PMID:15543949 3,4-dichloroaniline increases expression ISO RGD:734028 6480464 3, 4-dichloroaniline results in increased expression of NT5E mRNA CTD PMID:24172598 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:62249 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of NT5E mRNA CTD PMID:26251327 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of NT5E mRNA CTD PMID:28522335 4,4'-diaminodiphenylmethane affects expression ISO RGD:62249 6480464 4, 4'-diaminodiphenylmethane affects the expression of NT5E mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:62249 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NT5E mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:62249 6480464 Fenretinide results in decreased expression of NT5E mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:62249 6480464 Fenretinide results in increased expression of NT5E mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO RGD:734028 6480464 Decitabine results in increased expression of NT5E mRNA CTD PMID:16367923 5-azacytidine increases expression ISO RGD:734028 6480464 Azacitidine results in increased expression of NT5E mRNA CTD PMID:20823114 5-fluorouracil increases expression ISO RGD:734028 6480464 Fluorouracil results in increased expression of NT5E mRNA CTD PMID:24737281 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of NT5E mRNA CTD PMID:24780913 adenosine multiple interactions ISO RGD:62249 6480464 [alpha, beta-methyleneadenosine 5'-diphosphate results in decreased activity of NT5E protein] inhibits the reaction [Oxygen deficiency results in increased abundance of Adenosine] CTD PMID:23437309 ADP decreases activity ISO RGD:734028 6480464 Adenosine Diphosphate analog results in decreased activity of NT5E protein CTD PMID:18404487 aflatoxin B1 decreases expression ISO RGD:62249 6480464 Aflatoxin B1 results in decreased expression of NT5E mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:734028 6480464 Tretinoin results in increased expression of NT5E mRNA CTD PMID:23830798 antimycin A increases expression ISO RGD:62249 6480464 Antimycin A results in increased expression of NT5E mRNA CTD PMID:19304788 arsenous acid decreases expression ISO RGD:734028 6480464 Arsenic Trioxide results in decreased expression of NT5E mRNA CTD PMID:22521957 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of NT5E gene CTD PMID:28931070 benzo[a]pyrene multiple interactions ISO RGD:62249 6480464 Quercetin inhibits the reaction [Benzo(a)pyrene results in increased activity of NT5E protein] CTD PMID:18057710 benzo[a]pyrene increases activity ISO RGD:62249 6480464 Benzo(a)pyrene results in increased activity of NT5E protein CTD PMID:18057710 benzo[b]fluoranthene increases expression ISO RGD:62249 6480464 benzo(b)fluoranthene results in increased expression of NT5E mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate increases expression ISO RGD:734028 6480464 Diethylhexyl Phthalate results in increased expression of NT5E mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:734028 6480464 bisphenol A results in increased expression of NT5E mRNA CTD PMID:22576693 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NT5E mRNA CTD PMID:25181051 bisphenol A decreases methylation ISO RGD:734028 6480464 bisphenol A results in decreased methylation of NT5E gene CTD PMID:22576693 bisphenol F increases expression ISO RGD:62249 6480464 bisphenol F results in increased expression of NT5E mRNA CTD PMID:30951980 bortezomib decreases expression ISO RGD:734028 6480464 Bortezomib results in decreased expression of NT5E mRNA CTD PMID:20977926 bucladesine multiple interactions ISO RGD:734028 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of NT5E mRNA CTD PMID:20823114 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of NT5E mRNA CTD PMID:24136188 cadmium dichloride decreases expression ISO RGD:734028 6480464 Cadmium Chloride results in decreased expression of NT5E mRNA CTD PMID:26314618 caffeine decreases activity EXP 6480464 Caffeine results in decreased activity of NT5E protein CTD PMID:28465162 caffeine multiple interactions EXP 6480464 caffeic acid inhibits the reaction [Caffeine results in decreased activity of NT5E protein], Caffeine promotes the reaction [caffeic acid results in decreased activity of NT5E protein] CTD PMID:28465162 carbon nanotube decreases expression ISO RGD:62249 6480464 Nanotubes, Carbon analog results in decreased expression of NT5E mRNA CTD PMID:25620056 cerium trichloride decreases expression ISO RGD:62249 6480464 cerous chloride results in decreased expression of NT5E mRNA CTD PMID:23139204 chloropicrin decreases expression ISO RGD:734028 6480464 chloropicrin results in decreased expression of NT5E mRNA CTD PMID:28476498 chloropicrin affects expression ISO RGD:734028 6480464 chloropicrin affects the expression of NT5E mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:62249 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of NT5E mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NT5E mRNA CTD PMID:20938992 , PMID:29127188 ciguatoxin CTX1B affects expression ISO RGD:62249 6480464 Ciguatoxins affects the expression of NT5E mRNA CTD PMID:18353800 cis-caffeic acid multiple interactions EXP 6480464 caffeic acid inhibits the reaction [Caffeine results in decreased activity of NT5E protein], Caffeine promotes the reaction [caffeic acid results in decreased activity of NT5E protein] CTD PMID:28465162 cis-caffeic acid decreases activity EXP 6480464 caffeic acid results in decreased activity of NT5E protein CTD PMID:28465162 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of NT5E mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:734028 6480464 cobaltous chloride results in increased expression of NT5E protein CTD PMID:27899277 cobalt dichloride increases expression ISO RGD:62249 6480464 cobaltous chloride results in increased expression of NT5E protein CTD PMID:27590504 cobalt dichloride decreases expression ISO RGD:734028 6480464 cobaltous chloride results in decreased expression of NT5E mRNA CTD PMID:17553155 , PMID:19376846 copper atom decreases expression EXP 6480464 Copper results in decreased expression of NT5E mRNA CTD PMID:22465980 copper atom multiple interactions ISO RGD:734028 6480464 [Disulfiram binds to Copper] which results in increased expression of NT5E mRNA CTD PMID:24690739 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of NT5E mRNA CTD PMID:22465980 copper(0) multiple interactions ISO RGD:734028 6480464 [Disulfiram binds to Copper] which results in increased expression of NT5E mRNA CTD PMID:24690739 coumestrol multiple interactions ISO RGD:734028 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NT5E mRNA CTD PMID:19167446 coumestrol decreases expression ISO RGD:734028 6480464 Coumestrol results in decreased expression of NT5E mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:734028 6480464 Asbestos, Crocidolite results in increased expression of NT5E mRNA CTD PMID:18687144 cyclosporin A increases expression ISO RGD:734028 6480464 Cyclosporine results in increased expression of NT5E mRNA CTD PMID:21632981 cyclosporin A affects expression ISO RGD:734028 6480464 Cyclosporine affects the expression of NT5E mRNA CTD PMID:20106945 , PMID:25562108 Deguelin multiple interactions ISO RGD:734028 6480464 deguelin inhibits the reaction [Oxygen deficiency results in increased expression of NT5E protein] CTD PMID:27899277 dexamethasone increases expression ISO RGD:62249 6480464 Dexamethasone results in increased expression of NT5E mRNA CTD PMID:22733784 diarsenic trioxide decreases expression ISO RGD:734028 6480464 Arsenic Trioxide results in decreased expression of NT5E mRNA CTD PMID:22521957 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of NT5E mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:62249 6480464 Dibutyl Phthalate results in increased expression of NT5E mRNA CTD PMID:17361019 , PMID:21266533 dicrotophos decreases expression ISO RGD:734028 6480464 dicrotophos results in decreased expression of NT5E mRNA CTD PMID:28302478 dioxygen increases expression ISO RGD:62249 6480464 Oxygen deficiency results in increased expression of NT5E mRNA, Oxygen deficiency results in increased expression of NT5E protein CTD PMID:20880076 , PMID:23437309 dioxygen multiple interactions ISO RGD:734028 6480464 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the reaction [Oxygen deficiency results in increased expression of NT5E protein] more ... CTD PMID:27899277 dioxygen increases expression ISO RGD:734028 6480464 Oxygen deficiency results in increased expression of NT5E mRNA, Oxygen deficiency results in increased expression of NT5E protein CTD PMID:27899277 dioxygen multiple interactions ISO RGD:62249 6480464 [alpha, beta-methyleneadenosine 5'-diphosphate results in decreased activity of NT5E protein] inhibits the reaction [Oxygen deficiency results in increased abundance of Adenosine] CTD PMID:23437309 disulfiram multiple interactions ISO RGD:734028 6480464 [Disulfiram binds to Copper] which results in increased expression of NT5E mRNA CTD PMID:24690739 diuron decreases expression EXP 6480464 Diuron results in decreased expression of NT5E mRNA CTD PMID:25152437 diuron increases expression ISO RGD:734028 6480464 Diuron metabolite results in increased expression of NT5E mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:734028 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:734028 6480464 Doxorubicin results in decreased expression of NT5E mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of NT5E mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:734028 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NT5E mRNA CTD PMID:19167446 ethanol increases expression EXP 6480464 Ethanol results in increased expression of NT5E mRNA CTD PMID:17920746 ethanol multiple interactions ISO RGD:62249 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of NT5E mRNA CTD PMID:30517762 ethanol affects expression ISO RGD:62249 6480464 Ethanol affects the expression of NT5E mRNA CTD PMID:19167417 , PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:734028 6480464 Ethyl Methanesulfonate results in increased expression of NT5E mRNA CTD PMID:23649840 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of NT5E mRNA CTD PMID:24136188 , PMID:24793618 folic acid multiple interactions ISO RGD:62249 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of NT5E mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NT5E mRNA CTD PMID:20938992 , PMID:29127188 formaldehyde increases expression ISO RGD:734028 6480464 Formaldehyde results in increased expression of NT5E mRNA CTD PMID:23649840 formaldehyde decreases expression ISO RGD:734028 6480464 Formaldehyde results in decreased expression of NT5E mRNA CTD PMID:28937961 furan increases methylation EXP 6480464 furan results in increased methylation of NT5E gene CTD PMID:22079235 genistein decreases expression ISO RGD:734028 6480464 Genistein results in decreased expression of NT5E mRNA CTD PMID:26865667 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of NT5E mRNA CTD PMID:22061828 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of NT5E mRNA CTD PMID:24136188 homocysteine affects activity ISO RGD:62249 6480464 Homocysteine affects the activity of NT5E protein CTD PMID:24055814 indometacin multiple interactions ISO RGD:734028 6480464 Indomethacin results in increased expression of and results in increased activity of NT5E protein CTD PMID:17568578 indometacin increases expression ISO RGD:734028 6480464 Indomethacin results in increased expression of NT5E mRNA CTD PMID:17568578 L-methionine multiple interactions ISO RGD:62249 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of NT5E mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NT5E mRNA CTD PMID:20938992 , PMID:29127188 medroxyprogesterone acetate decreases expression ISO RGD:734028 6480464 Medroxyprogesterone Acetate results in decreased expression of NT5E mRNA CTD PMID:20843944 medroxyprogesterone acetate multiple interactions ISO RGD:734028 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of NT5E mRNA CTD PMID:20823114 mercury dibromide multiple interactions ISO RGD:734028 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NT5E mRNA CTD PMID:27188386 mercury dichloride decreases activity EXP 6480464 Mercuric Chloride results in decreased activity of NT5E protein CTD PMID:22416658 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of NT5E mRNA CTD PMID:30467583 N-nitrosodiethylamine multiple interactions ISO RGD:62249 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NT5E mRNA CTD PMID:24535843 N-nitrosodiethylamine increases expression ISO RGD:62249 6480464 Diethylnitrosamine results in increased expression of NT5E mRNA CTD PMID:24535843 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of NT5E mRNA CTD PMID:24136188 nickel atom increases expression ISO RGD:734028 6480464 Nickel results in increased expression of NT5E mRNA CTD PMID:24768652 , PMID:25583101 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of NT5E mRNA CTD PMID:24136188 nimesulide multiple interactions ISO RGD:62249 6480464 NT5E protein affects the reaction [nimesulide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased abundance of Nitrites]] CTD PMID:27188793 nitrites multiple interactions ISO RGD:62249 6480464 NT5E protein affects the reaction [nimesulide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased abundance of Nitrites]] CTD PMID:27188793 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of NT5E mRNA CTD PMID:25729387 paracetamol decreases expression ISO RGD:734028 6480464 Acetaminophen results in decreased expression of NT5E mRNA CTD PMID:21420995 , PMID:22230336 paraquat increases expression ISO RGD:62249 6480464 Paraquat results in increased expression of NT5E mRNA CTD PMID:12595580 perfluorooctane-1-sulfonic acid affects expression ISO RGD:62249 6480464 perfluorooctane sulfonic acid affects the expression of NT5E mRNA CTD PMID:19429403 perfluorooctanoic acid affects expression ISO RGD:62249 6480464 perfluorooctanoic acid affects the expression of NT5E mRNA CTD PMID:19429403 phenobarbital increases expression ISO RGD:62249 6480464 Phenobarbital results in increased expression of NT5E mRNA CTD PMID:19482888 phenobarbital affects expression ISO RGD:62249 6480464 Phenobarbital affects the expression of NT5E mRNA CTD PMID:23091169 phenobarbital multiple interactions ISO RGD:62249 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NT5E mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NT5E mRNA] CTD PMID:19482888 , PMID:24535843 phenylmercury acetate increases expression ISO RGD:734028 6480464 Phenylmercuric Acetate results in increased expression of NT5E mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:734028 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NT5E mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:734028 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NT5E mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:62249 6480464 pirinixic acid results in increased expression of NT5E mRNA CTD PMID:20813756 , PMID:23811191 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of NT5E mRNA CTD PMID:16940010 pirinixic acid decreases expression ISO RGD:62249 6480464 pirinixic acid results in decreased expression of NT5E mRNA CTD PMID:17426115 pirinixic acid multiple interactions ISO RGD:62249 6480464 [pirinixic acid co-treated with PPARA] results in increased expression of NT5E mRNA CTD PMID:20813756 potassium chromate increases expression ISO RGD:734028 6480464 potassium chromate(VI) results in increased expression of NT5E mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:62249 6480464 Pregnenolone Carbonitrile results in decreased expression of NT5E mRNA CTD PMID:28903501 progesterone increases expression EXP 6480464 Progesterone results in increased expression of NT5E mRNA CTD PMID:20726854 progesterone decreases expression ISO RGD:734028 6480464 Progesterone results in decreased expression of NT5E mRNA CTD PMID:20864642 quercetin decreases activity ISO RGD:734028 6480464 Quercetin results in decreased activity of NT5E protein CTD PMID:17643826 quercetin decreases expression ISO RGD:62249 6480464 Quercetin results in decreased expression of NT5E mRNA CTD PMID:25862958 quercetin decreases expression ISO RGD:734028 6480464 Quercetin results in decreased expression of NT5E mRNA CTD PMID:17643826 , PMID:21632981 quercetin multiple interactions ISO RGD:62249 6480464 Quercetin inhibits the reaction [Benzo(a)pyrene results in increased activity of NT5E protein] CTD PMID:18057710 rotenone increases expression ISO RGD:62249 6480464 Rotenone results in increased expression of NT5E mRNA CTD PMID:19304788 SB 431542 multiple interactions ISO RGD:734028 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:62249 6480464 Silicon Dioxide results in decreased expression of NT5E mRNA CTD PMID:29203145 sodium arsenate increases expression ISO RGD:62249 6480464 sodium arsenate results in increased expression of NT5E mRNA CTD PMID:21795629 sodium dichromate decreases expression ISO RGD:62249 6480464 sodium bichromate results in decreased expression of NT5E mRNA CTD PMID:22155349 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of NT5E mRNA CTD PMID:22561333 streptozocin multiple interactions ISO RGD:62249 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of NT5E mRNA CTD PMID:29127188 tenofovir disoproxil fumarate increases expression ISO RGD:734028 6480464 Tenofovir results in increased expression of NT5E mRNA CTD PMID:24205323 testosterone decreases expression ISO RGD:62249 6480464 Testosterone results in decreased expression of NT5E mRNA CTD PMID:15788153 more ... tetrachloromethane multiple interactions ISO RGD:62249 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of NT5E mRNA more ... CTD PMID:18263696 , PMID:30517762 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NT5E mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of NT5E mRNA CTD PMID:31150632 tetrachloromethane affects expression ISO RGD:62249 6480464 Carbon Tetrachloride affects the expression of NT5E mRNA CTD PMID:17484886 tetrachloromethane increases response to substance ISO RGD:62249 6480464 NT5E protein results in increased susceptibility to Carbon Tetrachloride CTD PMID:18263696 thalidomide decreases expression ISO RGD:62249 6480464 Thalidomide results in decreased expression of NT5E mRNA CTD PMID:26217789 thioacetamide increases response to substance ISO RGD:62249 6480464 NT5E protein results in increased susceptibility to Thioacetamide CTD PMID:18263696 thioacetamide decreases response to substance ISO RGD:62249 6480464 NT5E protein results in decreased susceptibility to Thioacetamide CTD PMID:27899277 thioacetamide increases expression ISO RGD:62249 6480464 Thioacetamide results in increased expression of NT5E mRNA, Thioacetamide results in increased expression of NT5E protein CTD PMID:27899277 trans-caffeic acid multiple interactions EXP 6480464 caffeic acid inhibits the reaction [Caffeine results in decreased activity of NT5E protein], Caffeine promotes the reaction [caffeic acid results in decreased activity of NT5E protein] CTD PMID:28465162 trans-caffeic acid decreases activity EXP 6480464 caffeic acid results in decreased activity of NT5E protein CTD PMID:28465162 trichostatin A increases expression ISO RGD:734028 6480464 trichostatin A results in increased expression of NT5E mRNA CTD PMID:24935251 tris(2-butoxyethyl) phosphate decreases expression ISO RGD:734028 6480464 tris(2-butoxyethyl) phosphate results in decreased expression of NT5E mRNA CTD PMID:29024780 troglitazone increases expression ISO RGD:62249 6480464 troglitazone results in increased expression of NT5E mRNA CTD PMID:28973697 uranium atom affects expression ISO RGD:734028 6480464 Uranium affects the expression of NT5E mRNA CTD PMID:15672453 valproic acid decreases expression ISO RGD:734028 6480464 Valproic Acid results in decreased expression of NT5E mRNA CTD PMID:23179753 valproic acid increases expression ISO RGD:734028 6480464 Valproic Acid results in increased expression of NT5E mRNA CTD PMID:24935251 valproic acid decreases methylation ISO RGD:734028 6480464 Valproic Acid results in decreased methylation of NT5E gene CTD PMID:29154799 vincristine increases expression ISO RGD:734028 6480464 Vincristine results in increased expression of NT5E mRNA CTD PMID:23649840
Gene-Chemical Interaction Annotations
